BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21352343)

  • 41. Role of endothelin-1 in the skin fibrosis of systemic sclerosis.
    Jing J; Dou TT; Yang JQ; Chen XB; Cao HL; Min M; Cai SQ; Zheng M; Man XY
    Eur Cytokine Netw; 2015; 26(1):10-4. PubMed ID: 25990837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
    Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
    J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T; Kähäri VM; Black C; Vuorio E
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
    Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
    Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Essential role of connective tissue growth factor (CTGF) in transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation from Graves' orbital fibroblasts.
    Tsai CC; Wu SB; Kau HC; Wei YH
    Sci Rep; 2018 May; 8(1):7276. PubMed ID: 29739987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
    Ohashi T; Yamamoto T
    Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. c-Abl silencing reduced the inhibitory effects of TGF-β1 on apoptosis in systemic sclerosis dermal fibroblasts.
    Karimizadeh E; Gharibdoost F; Motamed N; Jafarinejad-Farsangi S; Jamshidi A; Mahmoudi M
    Mol Cell Biochem; 2015 Jul; 405(1-2):169-76. PubMed ID: 25876876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis.
    Almadori A; Griffin M; Ryan CM; Hunt DF; Hansen E; Kumar R; Abraham DJ; Denton CP; Butler PEM
    PLoS One; 2019; 14(7):e0218068. PubMed ID: 31314805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts.
    Yamane K; Ihn H; Kubo M; Tamaki K
    Arthritis Rheum; 2002 Sep; 46(9):2421-8. PubMed ID: 12355490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
    Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
    J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis.
    Makino K; Makino T; Stawski L; Mantero JC; Lafyatis R; Simms R; Trojanowska M
    J Invest Dermatol; 2017 Aug; 137(8):1671-1681. PubMed ID: 28433542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva.
    Hong HH; Uzel MI; Duan C; Sheff MC; Trackman PC
    Lab Invest; 1999 Dec; 79(12):1655-67. PubMed ID: 10616214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis.
    Hemmatazad H; Rodrigues HM; Maurer B; Brentano F; Pileckyte M; Distler JH; Gay RE; Michel BA; Gay S; Huber LC; Distler O; Jüngel A
    Arthritis Rheum; 2009 May; 60(5):1519-29. PubMed ID: 19404935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of connective tissue growth factor/CCN2 expression in human dermal fibroblasts by interleukin-1alpha and beta.
    Nowinski D; Koskela A; Kiwanuka E; Boström M; Gerdin B; Ivarsson M
    J Cell Biochem; 2010 Aug; 110(5):1226-33. PubMed ID: 20544797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy.
    Fang F; Liu L; Yang Y; Tamaki Z; Wei J; Marangoni RG; Bhattacharyya S; Summer RS; Ye B; Varga J
    Arthritis Res Ther; 2012 Oct; 14(5):R229. PubMed ID: 23092446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Down-regulation of collagen and connective tissue growth factor expression with hepatocyte growth factor in lung fibroblasts from white scleroderma patients via two signaling pathways.
    Bogatkevich GS; Ludwicka-Bradley A; Highland KB; Hant F; Nietert PJ; Singleton CB; Silver RM
    Arthritis Rheum; 2007 Oct; 56(10):3468-77. PubMed ID: 17907155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
    Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
    Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
    Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.